|
|
 |
|
Viewing report
|
|
|
|
Emerging Drug Discovery Technologies: Building competitive advantage through lab-on-a-chip, nanotechnology and RNAi
Business Insights, April 2005, Pages: 186
The last decade has been marked by an unprecedented boom in the number and variety of technologies used to discover and develop new drugs; many of these technologies arose from work surrounding the human genome project. For example, gene sequencing, gene expression profiling and genotyping have greatly benefited from technological advances, resulting in dramatically higher throughputs and rapid declines in cost. For some other areas it has proven to be more of a challenge to achieve performance improvements of the same magnitude. Defining the function of each gene, or more specifically, the protein it encodes, has been particularly challenging. It is not yet possible to study gene function with the type of 'massively parallel' approaches used in other fields.
Customers who bought this item also bought
RNAi - Technologies, Markets and Companies
RNAi 2008
Advances in Lab-on-Chip and Microfluidics Technologies for Drug Discovery and Clinical Diagnostics
The Outlook For RNAi: Accelerating Drug Discovery and the Development of RNAi Therapeutics
Outlook for RNAi, 2007: siRNA and miRNA in Biology, Diagnostics and Therapeutics
Lab on a Chip (LOC) -- Advances in Microfluidics
The Future of RNAi Therapeutics: Drug Pipelines and Prospects
Realizing the Promise of Therapeutic RNAi: Emerging Strategies for RNAi Delivery
RNA Interference for Drug R&D: Applications, Alliances, Companies and WW Market to 2011
Drug Discovery Technologies - A Global Update of Market Trends & Opportunities
The Role of Nanotechnology in European Drug Discovery
RNAi Therapeutics 2008 Market Report
|
|
|
|
